| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocardial Infarction | 93 | 2024 | 1374 | 21.990 |
Why?
|
| Ventricular Remodeling | 47 | 2020 | 248 | 12.640 |
Why?
|
| Myocardium | 46 | 2024 | 1313 | 9.740 |
Why?
|
| Extracellular Matrix | 25 | 2022 | 554 | 7.260 |
Why?
|
| Fibroblasts | 41 | 2024 | 1682 | 7.190 |
Why?
|
| Fibrosis | 41 | 2024 | 793 | 6.450 |
Why?
|
| Smad3 Protein | 11 | 2022 | 129 | 5.890 |
Why?
|
| Myocytes, Cardiac | 25 | 2022 | 764 | 5.670 |
Why?
|
| Myofibroblasts | 19 | 2022 | 133 | 5.520 |
Why?
|
| Transforming Growth Factor beta | 30 | 2024 | 1130 | 4.860 |
Why?
|
| Macrophages | 29 | 2023 | 1304 | 4.410 |
Why?
|
| Extracellular Matrix Proteins | 14 | 2022 | 315 | 3.990 |
Why?
|
| Chemokines | 19 | 2020 | 314 | 3.850 |
Why?
|
| Myocardial Reperfusion Injury | 16 | 2021 | 197 | 3.590 |
Why?
|
| Inflammation | 34 | 2022 | 2522 | 3.550 |
Why?
|
| Pericytes | 5 | 2024 | 96 | 3.490 |
Why?
|
| Heart Failure | 19 | 2024 | 2516 | 3.470 |
Why?
|
| Cardiomyopathies | 12 | 2022 | 610 | 3.310 |
Why?
|
| Myocardial Ischemia | 12 | 2021 | 435 | 2.590 |
Why?
|
| Galectin 3 | 5 | 2023 | 138 | 2.590 |
Why?
|
| Regeneration | 8 | 2017 | 279 | 2.520 |
Why?
|
| Animals | 125 | 2023 | 59536 | 2.500 |
Why?
|
| Smad2 Protein | 4 | 2022 | 89 | 2.310 |
Why?
|
| Collagen | 15 | 2022 | 752 | 2.230 |
Why?
|
| Cardiomegaly | 5 | 2018 | 195 | 2.090 |
Why?
|
| Wound Healing | 14 | 2020 | 815 | 2.070 |
Why?
|
| Diabetic Cardiomyopathies | 4 | 2021 | 21 | 2.030 |
Why?
|
| Signal Transduction | 37 | 2020 | 11965 | 1.980 |
Why?
|
| Transglutaminases | 3 | 2018 | 99 | 1.820 |
Why?
|
| Mice, Knockout | 29 | 2023 | 5710 | 1.780 |
Why?
|
| GTP-Binding Proteins | 3 | 2018 | 321 | 1.680 |
Why?
|
| Chemokine CCL2 | 8 | 2016 | 203 | 1.640 |
Why?
|
| Thrombospondin 1 | 5 | 2013 | 55 | 1.640 |
Why?
|
| Anti-Inflammatory Agents | 4 | 2020 | 461 | 1.630 |
Why?
|
| Heart | 12 | 2024 | 1223 | 1.600 |
Why?
|
| Cytokines | 23 | 2022 | 2809 | 1.570 |
Why?
|
| Monocytes | 8 | 2022 | 788 | 1.510 |
Why?
|
| Mice, Inbred C57BL | 30 | 2022 | 6942 | 1.440 |
Why?
|
| Mice | 56 | 2023 | 34495 | 1.430 |
Why?
|
| Endomyocardial Fibrosis | 3 | 2018 | 9 | 1.360 |
Why?
|
| Immune System | 4 | 2017 | 279 | 1.300 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 4 | 2023 | 134 | 1.270 |
Why?
|
| Smad Proteins | 6 | 2020 | 88 | 1.260 |
Why?
|
| Myocarditis | 5 | 2013 | 190 | 1.230 |
Why?
|
| Hypertrophy, Left Ventricular | 5 | 2018 | 112 | 1.220 |
Why?
|
| Integrins | 4 | 2022 | 262 | 1.160 |
Why?
|
| Receptors, Interleukin-1 Type I | 3 | 2013 | 18 | 1.150 |
Why?
|
| Diabetes Mellitus | 4 | 2023 | 1054 | 1.120 |
Why?
|
| Myocardial Reperfusion | 7 | 2021 | 108 | 1.120 |
Why?
|
| Heart Diseases | 5 | 2016 | 732 | 1.110 |
Why?
|
| Smad7 Protein | 2 | 2022 | 16 | 1.080 |
Why?
|
| Platelet-Derived Growth Factor | 2 | 2021 | 157 | 1.050 |
Why?
|
| Phenotype | 13 | 2024 | 6295 | 1.040 |
Why?
|
| Stroke Volume | 4 | 2024 | 577 | 1.000 |
Why?
|
| Humans | 96 | 2024 | 261506 | 1.000 |
Why?
|
| Obesity | 7 | 2018 | 2884 | 0.990 |
Why?
|
| Heart Failure, Diastolic | 2 | 2017 | 11 | 0.990 |
Why?
|
| Receptors, Transforming Growth Factor beta | 3 | 2023 | 229 | 0.980 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 2 | 2015 | 39 | 0.980 |
Why?
|
| Integrin alpha5 | 1 | 2023 | 15 | 0.960 |
Why?
|
| Pressure | 3 | 2019 | 215 | 0.930 |
Why?
|
| Biomarkers | 10 | 2023 | 5047 | 0.920 |
Why?
|
| Transforming Growth Factor beta1 | 4 | 2019 | 292 | 0.900 |
Why?
|
| Mast Cells | 7 | 2019 | 223 | 0.890 |
Why?
|
| Chemokine CXCL12 | 3 | 2014 | 132 | 0.890 |
Why?
|
| Cell Movement | 8 | 2014 | 2466 | 0.860 |
Why?
|
| Inflammation Mediators | 9 | 2019 | 423 | 0.850 |
Why?
|
| Stress, Mechanical | 3 | 2019 | 311 | 0.840 |
Why?
|
| Muramidase | 1 | 2022 | 110 | 0.840 |
Why?
|
| Phagocytosis | 2 | 2022 | 260 | 0.840 |
Why?
|
| Chemokine CXCL10 | 2 | 2014 | 105 | 0.830 |
Why?
|
| Complement Activation | 4 | 2017 | 94 | 0.820 |
Why?
|
| Disease Models, Animal | 18 | 2021 | 7222 | 0.810 |
Why?
|
| Matrix Metalloproteinase 14 | 1 | 2021 | 18 | 0.810 |
Why?
|
| Up-Regulation | 8 | 2018 | 2450 | 0.790 |
Why?
|
| Aging | 4 | 2018 | 1582 | 0.790 |
Why?
|
| Peripheral Arterial Disease | 2 | 2018 | 267 | 0.780 |
Why?
|
| Heart Rupture | 1 | 2020 | 5 | 0.770 |
Why?
|
| Gene Expression Regulation | 10 | 2020 | 4053 | 0.770 |
Why?
|
| Semantics | 1 | 2020 | 58 | 0.760 |
Why?
|
| Immunity, Innate | 5 | 2017 | 677 | 0.750 |
Why?
|
| Neutrophil Infiltration | 5 | 2013 | 109 | 0.750 |
Why?
|
| Ventricular Dysfunction, Left | 4 | 2018 | 435 | 0.740 |
Why?
|
| Neovascularization, Physiologic | 7 | 2017 | 345 | 0.740 |
Why?
|
| Calgranulin A | 1 | 2019 | 12 | 0.720 |
Why?
|
| Interleukin-1 | 2 | 2013 | 461 | 0.710 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2019 | 33 | 0.700 |
Why?
|
| Ventricular Function, Left | 4 | 2020 | 603 | 0.680 |
Why?
|
| Myocardial Contraction | 4 | 2015 | 291 | 0.660 |
Why?
|
| Endothelium, Vascular | 5 | 2013 | 891 | 0.650 |
Why?
|
| RNA | 4 | 2023 | 1013 | 0.650 |
Why?
|
| Mitochondria, Heart | 1 | 2018 | 72 | 0.640 |
Why?
|
| Actins | 3 | 2016 | 608 | 0.640 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 2017 | 14 | 0.630 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2017 | 29 | 0.610 |
Why?
|
| Cells, Cultured | 11 | 2019 | 5637 | 0.600 |
Why?
|
| Mechanotransduction, Cellular | 2 | 2021 | 88 | 0.600 |
Why?
|
| Calcium Channels | 1 | 2018 | 197 | 0.590 |
Why?
|
| Cardiology | 2 | 2020 | 530 | 0.580 |
Why?
|
| Receptors, CXCR3 | 2 | 2014 | 36 | 0.580 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2017 | 74 | 0.580 |
Why?
|
| Ventricular Function, Right | 1 | 2017 | 111 | 0.580 |
Why?
|
| Phagocytes | 2 | 2014 | 44 | 0.580 |
Why?
|
| Cultural Diversity | 1 | 2016 | 76 | 0.550 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2019 | 673 | 0.550 |
Why?
|
| Glycation End Products, Advanced | 1 | 2015 | 31 | 0.550 |
Why?
|
| Adiposity | 2 | 2018 | 237 | 0.540 |
Why?
|
| Oncostatin M | 1 | 2015 | 23 | 0.530 |
Why?
|
| Coronary Disease | 1 | 2019 | 764 | 0.530 |
Why?
|
| Acute Coronary Syndrome | 2 | 2009 | 259 | 0.520 |
Why?
|
| Betacoronavirus | 1 | 2020 | 527 | 0.520 |
Why?
|
| Cardiotonic Agents | 2 | 2014 | 151 | 0.510 |
Why?
|
| Adaptation, Physiological | 2 | 2019 | 360 | 0.510 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2018 | 406 | 0.500 |
Why?
|
| Echocardiography | 9 | 2017 | 1182 | 0.500 |
Why?
|
| Tenascin | 3 | 2020 | 56 | 0.500 |
Why?
|
| Lectins, C-Type | 1 | 2015 | 162 | 0.500 |
Why?
|
| Dogs | 10 | 2007 | 1155 | 0.500 |
Why?
|
| Azabicyclo Compounds | 1 | 2014 | 36 | 0.490 |
Why?
|
| Myocardial Stunning | 3 | 2003 | 21 | 0.490 |
Why?
|
| Peptides | 1 | 2020 | 1479 | 0.480 |
Why?
|
| Leukocytes | 7 | 2017 | 422 | 0.470 |
Why?
|
| Angiopoietin-2 | 1 | 2013 | 38 | 0.470 |
Why?
|
| Heart Ventricles | 2 | 2018 | 846 | 0.460 |
Why?
|
| Proteoglycans | 1 | 2014 | 259 | 0.460 |
Why?
|
| Male | 38 | 2021 | 123000 | 0.450 |
Why?
|
| Sirtuin 1 | 1 | 2013 | 89 | 0.450 |
Why?
|
| Reactive Oxygen Species | 7 | 2018 | 987 | 0.450 |
Why?
|
| Aorta | 2 | 2015 | 692 | 0.450 |
Why?
|
| S100 Proteins | 1 | 2013 | 181 | 0.450 |
Why?
|
| Female | 38 | 2023 | 141928 | 0.440 |
Why?
|
| Recovery of Function | 5 | 2012 | 703 | 0.440 |
Why?
|
| Neutrophils | 7 | 2020 | 835 | 0.440 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2020 | 830 | 0.440 |
Why?
|
| Interleukins | 1 | 2015 | 325 | 0.440 |
Why?
|
| Vasodilation | 1 | 2013 | 205 | 0.440 |
Why?
|
| Interleukin-1beta | 2 | 2016 | 300 | 0.430 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 651 | 0.430 |
Why?
|
| Aortic Aneurysm | 1 | 2015 | 230 | 0.430 |
Why?
|
| Cell-Derived Microparticles | 1 | 2012 | 41 | 0.430 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 715 | 0.420 |
Why?
|
| Lysophospholipids | 1 | 2012 | 147 | 0.410 |
Why?
|
| Thrombospondins | 2 | 2012 | 21 | 0.410 |
Why?
|
| Spleen | 1 | 2014 | 676 | 0.400 |
Why?
|
| Atherosclerosis | 1 | 2019 | 935 | 0.400 |
Why?
|
| Adipocytes | 1 | 2013 | 305 | 0.390 |
Why?
|
| Pandemics | 1 | 2020 | 1559 | 0.390 |
Why?
|
| Reperfusion Injury | 3 | 2007 | 145 | 0.390 |
Why?
|
| RNA, Messenger | 12 | 2015 | 6150 | 0.390 |
Why?
|
| Mammals | 2 | 2023 | 361 | 0.380 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 1362 | 0.370 |
Why?
|
| Interleukin-10 | 3 | 2010 | 478 | 0.370 |
Why?
|
| Receptors, CCR5 | 1 | 2010 | 52 | 0.370 |
Why?
|
| Cicatrix | 4 | 2022 | 208 | 0.360 |
Why?
|
| Syndecan-1 | 1 | 2010 | 52 | 0.360 |
Why?
|
| Bone Marrow | 1 | 2018 | 2358 | 0.360 |
Why?
|
| Receptors, CXCR4 | 1 | 2011 | 269 | 0.350 |
Why?
|
| Metalloproteases | 1 | 2009 | 24 | 0.350 |
Why?
|
| Drug Delivery Systems | 1 | 2014 | 669 | 0.350 |
Why?
|
| Receptors, Chemokine | 2 | 2007 | 114 | 0.350 |
Why?
|
| Toll-Like Receptors | 3 | 2019 | 174 | 0.340 |
Why?
|
| Interleukin-1alpha | 1 | 2009 | 56 | 0.340 |
Why?
|
| Mice, Transgenic | 4 | 2022 | 4143 | 0.340 |
Why?
|
| C-Reactive Protein | 1 | 2012 | 527 | 0.340 |
Why?
|
| Leptin | 1 | 2010 | 295 | 0.340 |
Why?
|
| Gene Expression | 6 | 2020 | 3570 | 0.330 |
Why?
|
| Antigens, Neoplasm | 1 | 2015 | 1506 | 0.320 |
Why?
|
| Myeloid Cells | 2 | 2020 | 269 | 0.320 |
Why?
|
| Coronary Vessels | 2 | 2004 | 665 | 0.320 |
Why?
|
| Metabolomics | 1 | 2012 | 478 | 0.320 |
Why?
|
| Cell Adhesion Molecules | 4 | 2019 | 577 | 0.320 |
Why?
|
| Adipose Tissue | 1 | 2013 | 769 | 0.310 |
Why?
|
| Apoptosis | 4 | 2023 | 7591 | 0.300 |
Why?
|
| Mice, Obese | 3 | 2018 | 104 | 0.300 |
Why?
|
| Diet | 2 | 2013 | 1440 | 0.300 |
Why?
|
| Immunohistochemistry | 10 | 2013 | 7548 | 0.300 |
Why?
|
| Diastole | 3 | 2018 | 187 | 0.290 |
Why?
|
| Hyaluronan Receptors | 1 | 2008 | 249 | 0.290 |
Why?
|
| Proteins | 1 | 2015 | 1963 | 0.290 |
Why?
|
| Hypertension | 2 | 2018 | 1503 | 0.290 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2006 | 104 | 0.280 |
Why?
|
| Echocardiography, Doppler | 2 | 2018 | 180 | 0.280 |
Why?
|
| Chronic Disease | 1 | 2012 | 1819 | 0.280 |
Why?
|
| Serine Endopeptidases | 2 | 2005 | 275 | 0.280 |
Why?
|
| Tissue Survival | 1 | 2005 | 15 | 0.270 |
Why?
|
| Sex Factors | 3 | 2021 | 2139 | 0.270 |
Why?
|
| Disease Progression | 4 | 2021 | 6682 | 0.270 |
Why?
|
| Coronary Artery Disease | 3 | 2017 | 1011 | 0.270 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 2 | 2021 | 153 | 0.270 |
Why?
|
| Myosin Heavy Chains | 2 | 2004 | 128 | 0.270 |
Why?
|
| Cell Proliferation | 7 | 2017 | 7226 | 0.250 |
Why?
|
| Ischemia | 2 | 2007 | 391 | 0.250 |
Why?
|
| Endothelial Cells | 3 | 2020 | 1048 | 0.250 |
Why?
|
| Chemokine CCL5 | 1 | 2004 | 71 | 0.250 |
Why?
|
| Receptors, CCR2 | 2 | 2019 | 41 | 0.240 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 2 | 2018 | 43 | 0.240 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2023 | 72 | 0.230 |
Why?
|
| Matrix Metalloproteinase 2 | 2 | 2017 | 256 | 0.230 |
Why?
|
| CD11b Antigen | 2 | 2013 | 66 | 0.230 |
Why?
|
| Cell Transdifferentiation | 2 | 2015 | 112 | 0.230 |
Why?
|
| DNA | 1 | 2011 | 2693 | 0.230 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2003 | 72 | 0.230 |
Why?
|
| Cell Separation | 2 | 2015 | 612 | 0.220 |
Why?
|
| Renin-Angiotensin System | 2 | 2015 | 103 | 0.220 |
Why?
|
| Time Factors | 8 | 2018 | 12926 | 0.220 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2004 | 330 | 0.210 |
Why?
|
| Chemokine CCL3 | 2 | 2014 | 63 | 0.210 |
Why?
|
| Biomedical Research | 2 | 2021 | 806 | 0.210 |
Why?
|
| Molecular Targeted Therapy | 3 | 2020 | 2330 | 0.210 |
Why?
|
| Epigenesis, Genetic | 2 | 2020 | 1399 | 0.210 |
Why?
|
| Transforming Growth Factors | 1 | 2022 | 40 | 0.210 |
Why?
|
| Kupffer Cells | 1 | 2022 | 42 | 0.210 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2017 | 650 | 0.210 |
Why?
|
| Plant Lectins | 1 | 2002 | 27 | 0.210 |
Why?
|
| Cell Differentiation | 5 | 2015 | 4078 | 0.210 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2002 | 55 | 0.210 |
Why?
|
| Homeostasis | 2 | 2020 | 950 | 0.210 |
Why?
|
| Matrix Metalloproteinases | 2 | 2015 | 143 | 0.210 |
Why?
|
| Coronary Circulation | 4 | 2008 | 253 | 0.200 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2018 | 709 | 0.200 |
Why?
|
| TGF-beta Superfamily Proteins | 1 | 2020 | 2 | 0.200 |
Why?
|
| Genomics | 1 | 2012 | 2738 | 0.190 |
Why?
|
| Elastin | 1 | 2020 | 49 | 0.190 |
Why?
|
| Membrane Glycoproteins | 2 | 2003 | 1073 | 0.180 |
Why?
|
| T-Lymphocytes | 2 | 2010 | 3869 | 0.180 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2023 | 1678 | 0.180 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2020 | 54 | 0.180 |
Why?
|
| Endothelium | 1 | 2020 | 158 | 0.180 |
Why?
|
| MicroRNAs | 1 | 2013 | 2947 | 0.180 |
Why?
|
| Calgranulin B | 1 | 2019 | 22 | 0.180 |
Why?
|
| Fibronectins | 1 | 2020 | 197 | 0.180 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2019 | 7 | 0.180 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2019 | 19 | 0.170 |
Why?
|
| Cell Count | 2 | 2015 | 508 | 0.170 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2011 | 360 | 0.170 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2019 | 32 | 0.170 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 2019 | 57 | 0.170 |
Why?
|
| Proteolysis | 1 | 2021 | 370 | 0.170 |
Why?
|
| Placenta | 1 | 2023 | 516 | 0.170 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2019 | 66 | 0.170 |
Why?
|
| Endosomes | 1 | 2019 | 109 | 0.170 |
Why?
|
| Cholesterol | 1 | 2022 | 658 | 0.170 |
Why?
|
| Cellular Microenvironment | 1 | 2018 | 41 | 0.160 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2018 | 22 | 0.160 |
Why?
|
| Osteopontin | 2 | 2012 | 148 | 0.160 |
Why?
|
| Physiology | 1 | 2018 | 17 | 0.160 |
Why?
|
| Endothelial Progenitor Cells | 1 | 2018 | 13 | 0.160 |
Why?
|
| NADPH Oxidase 2 | 1 | 2017 | 47 | 0.160 |
Why?
|
| Necrosis | 2 | 2023 | 580 | 0.160 |
Why?
|
| Models, Cardiovascular | 2 | 2010 | 202 | 0.160 |
Why?
|
| Cardiovascular Agents | 1 | 2019 | 128 | 0.160 |
Why?
|
| Muscle Cells | 2 | 2010 | 38 | 0.160 |
Why?
|
| Machine Learning | 1 | 2020 | 319 | 0.160 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2022 | 661 | 0.160 |
Why?
|
| Chemokine CCL4 | 2 | 2010 | 63 | 0.150 |
Why?
|
| Pyrrolidines | 1 | 2018 | 113 | 0.150 |
Why?
|
| Fucosyltransferases | 1 | 2017 | 76 | 0.150 |
Why?
|
| Atrial Remodeling | 1 | 2017 | 12 | 0.150 |
Why?
|
| Isoxazoles | 1 | 2018 | 81 | 0.150 |
Why?
|
| Connexin 43 | 1 | 2017 | 46 | 0.150 |
Why?
|
| Calcium-Binding Proteins | 1 | 2020 | 545 | 0.150 |
Why?
|
| Neovascularization, Pathologic | 4 | 2006 | 1547 | 0.150 |
Why?
|
| Tachycardia | 1 | 2017 | 70 | 0.150 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2023 | 1533 | 0.150 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 1077 | 0.150 |
Why?
|
| Antigens, CD | 1 | 2002 | 1385 | 0.140 |
Why?
|
| Heart Rate | 1 | 2020 | 737 | 0.140 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2018 | 226 | 0.140 |
Why?
|
| Epithelial Cells | 2 | 2020 | 1818 | 0.140 |
Why?
|
| Cellular Senescence | 1 | 2018 | 382 | 0.140 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2018 | 204 | 0.140 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 10331 | 0.140 |
Why?
|
| Receptor for Advanced Glycation End Products | 1 | 2015 | 38 | 0.140 |
Why?
|
| Y-Box-Binding Protein 1 | 1 | 2015 | 36 | 0.140 |
Why?
|
| Cell Respiration | 1 | 2015 | 52 | 0.130 |
Why?
|
| Disease Susceptibility | 1 | 2018 | 538 | 0.130 |
Why?
|
| Cell Size | 1 | 2015 | 136 | 0.130 |
Why?
|
| Dilatation, Pathologic | 1 | 2015 | 88 | 0.130 |
Why?
|
| Vascular Remodeling | 1 | 2015 | 48 | 0.130 |
Why?
|
| Phosphorylation | 3 | 2015 | 4804 | 0.130 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2014 | 34 | 0.130 |
Why?
|
| Collagen Type I | 1 | 2015 | 204 | 0.130 |
Why?
|
| Quinolines | 1 | 2018 | 383 | 0.130 |
Why?
|
| Chemokines, CC | 2 | 2004 | 36 | 0.120 |
Why?
|
| Oxygen | 2 | 2017 | 754 | 0.120 |
Why?
|
| Glucose | 1 | 2020 | 1248 | 0.120 |
Why?
|
| Dobutamine | 2 | 2005 | 54 | 0.120 |
Why?
|
| Perfusion | 1 | 2015 | 293 | 0.120 |
Why?
|
| Lymphocytes | 2 | 2019 | 1234 | 0.120 |
Why?
|
| Aortic Rupture | 1 | 2015 | 113 | 0.120 |
Why?
|
| Receptors, Interleukin-1 Type II | 1 | 2013 | 6 | 0.120 |
Why?
|
| Immunologic Factors | 1 | 2018 | 649 | 0.120 |
Why?
|
| Communication | 1 | 2020 | 876 | 0.120 |
Why?
|
| Antigens, Ly | 1 | 2013 | 49 | 0.120 |
Why?
|
| Blotting, Western | 2 | 2011 | 3536 | 0.120 |
Why?
|
| Models, Biological | 3 | 2009 | 3254 | 0.120 |
Why?
|
| Tryptases | 2 | 2005 | 48 | 0.120 |
Why?
|
| CD11 Antigens | 1 | 2013 | 23 | 0.120 |
Why?
|
| Angiotensins | 1 | 2013 | 10 | 0.120 |
Why?
|
| S100 Calcium-Binding Protein A4 | 1 | 2013 | 57 | 0.120 |
Why?
|
| Chemokines, CXC | 1 | 2014 | 117 | 0.120 |
Why?
|
| Calorimetry, Indirect | 1 | 2013 | 60 | 0.120 |
Why?
|
| Arterioles | 2 | 2004 | 36 | 0.120 |
Why?
|
| Periodicals as Topic | 1 | 2018 | 338 | 0.110 |
Why?
|
| CD18 Antigens | 1 | 2013 | 83 | 0.110 |
Why?
|
| Sensitivity and Specificity | 3 | 2011 | 4971 | 0.110 |
Why?
|
| 3T3 Cells | 1 | 2013 | 355 | 0.110 |
Why?
|
| Cell Division | 2 | 2010 | 2489 | 0.110 |
Why?
|
| CCN Intercellular Signaling Proteins | 1 | 2012 | 7 | 0.110 |
Why?
|
| Contractile Proteins | 1 | 2012 | 43 | 0.110 |
Why?
|
| Biopsy | 1 | 2020 | 3443 | 0.110 |
Why?
|
| Hypertension, Pulmonary | 1 | 2017 | 462 | 0.110 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 2927 | 0.110 |
Why?
|
| Receptor, ErbB-2 | 1 | 2022 | 2518 | 0.100 |
Why?
|
| Leukocyte Common Antigens | 2 | 2009 | 188 | 0.100 |
Why?
|
| Acute Disease | 1 | 2017 | 2422 | 0.100 |
Why?
|
| Calcium | 1 | 2018 | 1537 | 0.100 |
Why?
|
| Transcriptome | 1 | 2020 | 1859 | 0.100 |
Why?
|
| Diet, High-Fat | 1 | 2013 | 241 | 0.100 |
Why?
|
| Species Specificity | 2 | 2021 | 777 | 0.100 |
Why?
|
| Hypoglycemic Agents | 1 | 2015 | 586 | 0.100 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2011 | 45 | 0.100 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 694 | 0.100 |
Why?
|
| Genes, Reporter | 1 | 2013 | 798 | 0.100 |
Why?
|
| Receptors, Leptin | 1 | 2010 | 62 | 0.100 |
Why?
|
| NF-kappa B | 2 | 2008 | 1549 | 0.090 |
Why?
|
| Mice, Mutant Strains | 2 | 2009 | 634 | 0.090 |
Why?
|
| Glycoproteins | 1 | 2014 | 747 | 0.090 |
Why?
|
| Down-Regulation | 1 | 2015 | 2074 | 0.090 |
Why?
|
| Pregnancy | 1 | 2023 | 7573 | 0.090 |
Why?
|
| Random Allocation | 1 | 2011 | 703 | 0.090 |
Why?
|
| Weight Gain | 1 | 2013 | 464 | 0.090 |
Why?
|
| Antibodies | 1 | 2013 | 838 | 0.090 |
Why?
|
| Blood Pressure | 1 | 2016 | 1467 | 0.090 |
Why?
|
| Age Factors | 2 | 2010 | 5377 | 0.090 |
Why?
|
| Transcription, Genetic | 1 | 2018 | 3154 | 0.090 |
Why?
|
| Insulin | 2 | 2013 | 1454 | 0.090 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 703 | 0.090 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 1217 | 0.090 |
Why?
|
| Angiotensin II | 1 | 2010 | 198 | 0.090 |
Why?
|
| Anti-Infective Agents | 1 | 2013 | 446 | 0.090 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2009 | 161 | 0.090 |
Why?
|
| Models, Animal | 1 | 2012 | 664 | 0.090 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2009 | 103 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2011 | 639 | 0.080 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2007 | 58 | 0.080 |
Why?
|
| Complement System Proteins | 1 | 2008 | 139 | 0.080 |
Why?
|
| Chymases | 2 | 2008 | 12 | 0.080 |
Why?
|
| Insulin Resistance | 1 | 2013 | 731 | 0.080 |
Why?
|
| Circadian Rhythm | 1 | 2009 | 330 | 0.080 |
Why?
|
| Carotid Arteries | 1 | 2008 | 240 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2006 | 80 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 3101 | 0.070 |
Why?
|
| Microcirculation | 1 | 2006 | 200 | 0.070 |
Why?
|
| Ultrasonography | 1 | 2012 | 1863 | 0.070 |
Why?
|
| Consensus | 2 | 2021 | 978 | 0.070 |
Why?
|
| Blood Vessels | 1 | 2006 | 217 | 0.070 |
Why?
|
| Fatty Acids | 1 | 2008 | 448 | 0.070 |
Why?
|
| Systole | 1 | 2005 | 196 | 0.070 |
Why?
|
| Lipid Metabolism | 1 | 2008 | 483 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2006 | 875 | 0.060 |
Why?
|
| Cell Communication | 1 | 2008 | 509 | 0.060 |
Why?
|
| Sialoglycoproteins | 1 | 2005 | 151 | 0.060 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 2004 | 34 | 0.060 |
Why?
|
| Cell Degranulation | 1 | 2005 | 47 | 0.060 |
Why?
|
| Prospective Studies | 1 | 2019 | 12873 | 0.060 |
Why?
|
| Chagas Cardiomyopathy | 1 | 2004 | 45 | 0.060 |
Why?
|
| Brain Ischemia | 1 | 2007 | 292 | 0.060 |
Why?
|
| Trans-Activators | 1 | 2010 | 1555 | 0.060 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2003 | 17 | 0.060 |
Why?
|
| Granuloma | 1 | 2005 | 154 | 0.060 |
Why?
|
| Thallium Radioisotopes | 1 | 2003 | 20 | 0.060 |
Why?
|
| Macrophage-1 Antigen | 1 | 2003 | 51 | 0.060 |
Why?
|
| Cardiac Catheterization | 1 | 2007 | 687 | 0.060 |
Why?
|
| Rats | 1 | 2012 | 6086 | 0.060 |
Why?
|
| Jugular Veins | 1 | 2003 | 107 | 0.060 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2023 | 367 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 3719 | 0.060 |
Why?
|
| Nonmuscle Myosin Type IIB | 1 | 2002 | 5 | 0.050 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2003 | 100 | 0.050 |
Why?
|
| Bone Marrow Cells | 1 | 2006 | 943 | 0.050 |
Why?
|
| CD146 Antigen | 1 | 2002 | 57 | 0.050 |
Why?
|
| Reperfusion | 1 | 2021 | 24 | 0.050 |
Why?
|
| Risk Factors | 2 | 2010 | 17523 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2004 | 842 | 0.050 |
Why?
|
| Capillaries | 1 | 2002 | 99 | 0.050 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2002 | 157 | 0.050 |
Why?
|
| Lectins | 1 | 2002 | 151 | 0.050 |
Why?
|
| Terminology as Topic | 1 | 2004 | 414 | 0.050 |
Why?
|
| Myocardial Revascularization | 1 | 2002 | 134 | 0.050 |
Why?
|
| Growth Substances | 1 | 2002 | 300 | 0.050 |
Why?
|
| Homozygote | 1 | 2023 | 717 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2007 | 4892 | 0.050 |
Why?
|
| Hemodynamics | 1 | 2005 | 935 | 0.050 |
Why?
|
| Antigens, Surface | 1 | 2002 | 295 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2002 | 699 | 0.050 |
Why?
|
| Staining and Labeling | 1 | 2002 | 429 | 0.050 |
Why?
|
| Amino Acid Sequence | 1 | 2007 | 4233 | 0.050 |
Why?
|
| Sequence Deletion | 1 | 2023 | 875 | 0.050 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 6089 | 0.040 |
Why?
|
| Isolated Heart Preparation | 1 | 2018 | 6 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2002 | 1764 | 0.040 |
Why?
|
| Kidney | 1 | 2007 | 2146 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2017 | 15 | 0.040 |
Why?
|
| Blood Platelets | 1 | 2003 | 731 | 0.040 |
Why?
|
| Data Accuracy | 1 | 2018 | 54 | 0.040 |
Why?
|
| Liver | 1 | 2007 | 2961 | 0.040 |
Why?
|
| Cell Survival | 1 | 2003 | 3045 | 0.040 |
Why?
|
| Aged | 4 | 2010 | 70117 | 0.040 |
Why?
|
| Quality Control | 1 | 2018 | 457 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 1538 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2017 | 272 | 0.030 |
Why?
|
| Contrast Media | 1 | 2003 | 1472 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2003 | 1756 | 0.030 |
Why?
|
| Logistic Models | 1 | 2002 | 3441 | 0.030 |
Why?
|
| Survival Rate | 1 | 2007 | 12221 | 0.030 |
Why?
|
| Glycosylation | 1 | 2014 | 213 | 0.030 |
Why?
|
| United States | 1 | 2010 | 15433 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2019 | 1085 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 2003 | 4367 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 1265 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 29902 | 0.020 |
Why?
|
| ARNTL Transcription Factors | 1 | 2009 | 57 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2009 | 107 | 0.020 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2009 | 57 | 0.020 |
Why?
|
| Prognosis | 1 | 2007 | 21713 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2009 | 163 | 0.020 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2008 | 25 | 0.020 |
Why?
|
| Wakefulness | 1 | 2009 | 150 | 0.020 |
Why?
|
| Middle Aged | 4 | 2003 | 86204 | 0.020 |
Why?
|
| Endocardium | 1 | 2007 | 50 | 0.020 |
Why?
|
| Heart Function Tests | 1 | 2007 | 73 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2007 | 333 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2017 | 2819 | 0.020 |
Why?
|
| Sleep | 1 | 2009 | 413 | 0.020 |
Why?
|
| Chimera | 1 | 2006 | 145 | 0.020 |
Why?
|
| Amyloid | 1 | 2006 | 97 | 0.020 |
Why?
|
| Triglycerides | 1 | 2008 | 603 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2009 | 803 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 482 | 0.020 |
Why?
|
| Cadherins | 1 | 2008 | 660 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2006 | 593 | 0.020 |
Why?
|
| Tachycardia, Ventricular | 1 | 2007 | 239 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2008 | 1244 | 0.010 |
Why?
|
| Ventricular Dysfunction | 1 | 2003 | 33 | 0.010 |
Why?
|
| P-Selectin | 1 | 2003 | 124 | 0.010 |
Why?
|
| Platelet Activation | 1 | 2003 | 116 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2003 | 573 | 0.010 |
Why?
|
| Superoxide Dismutase | 1 | 2003 | 266 | 0.010 |
Why?
|
| Platelet Aggregation | 1 | 2003 | 257 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2007 | 1145 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 2003 | 660 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2003 | 475 | 0.010 |
Why?
|
| Observer Variation | 1 | 2003 | 671 | 0.010 |
Why?
|
| ROC Curve | 1 | 2003 | 1183 | 0.010 |
Why?
|
| Body Weight | 1 | 2003 | 1293 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2009 | 4821 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2003 | 3033 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2009 | 5270 | 0.010 |
Why?
|
| Adult | 1 | 2003 | 77950 | 0.000 |
Why?
|